NLS Pharmaceutics AG logo

NLS Pharmaceutics AG


Overview | Financials
Company Name NLS Pharmaceutics AG
Symbol NLSP
Currency USD
Price 0.185
Market Cap 8,641,988
Dividend Yield 0%
52-week-range 0.111 - 1.205
Industry Biotechnology
Sector Healthcare
CEO Mr. Alexander Zwyer M.B.A.

An error occurred while fetching data.

About NLS Pharmaceutics AG

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention

Related Stocks

CNS Pharmaceuticals, Inc. logo

CNS Pharmaceuticals, Inc.


1.05 USD

Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp.


2.73 USD


Numbers are in millions USD

Numbers are in millions USD